Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-19-054152

COO and Secretary acquired 5,129 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Schuth Alexander O. COO and Secretary 2019-10-23 Option exercise +5,129 $5.28 $27,081 25,839 D
Derivatives
Schuth Alexander O. COO and Secretary 2019-10-23 Option exercise · Stock Option (right to buy) −5,129 112,769 D
Loading xslF345X03/doc4.xml…